Pink Sheet Podcast: Coronavirus Vaccine Selection Depends On Manufacturing, Hydroxychloroquine EUA Is Revoked, Rare Pediatric Disease Voucher Program In Danger
Executive Summary
Pink Sheet reporter and editor discuss Operation Warp Speed’s vaccine manufacturing goals, the US FDA’s decision to pull the hydroxychloroquine emergency use authorization, and the race to beat the eligibility deadline for a rare pediatric disease priority review voucher.